What is the single most important test in identifying the cause
of an IUFD?
A systematic pathologic examination of the fetus and placenta is
the single most useful test in identifying the cause of IUFD (1).
Such an examination can identify such causes as placental abruption,
cord accidents, and previously undiagnosed fetal structural anomalies
(such as anencephaly) (1-3). If the family declines a request for
fetopsy, a careful history and gross examination of the fetus alone
may be able to identify the cause in many instances (1). It should be
remembered that, even after intensive investigation, around 25-50% of
fetal demises will have no known cause (1-3).
What test should be performed immediately as it cannot be done
a few weeks later?
A Kleihauer-Betke (KB) test should be sent as soon as possible.
This is an acid elution test performed on maternal venous whole blood
that is designed to identify fetal cells within the maternal
circulation. The KB test will also estimate the quantity of the
fetal-maternal hemorrhage, although it is not particularly sensitive
at low volumes (<5-mL). This test is commonly used in Rh-negative
parturients to estimate the amount of RhoGAM that should be given to
prevent Rh isoimmunization. In the setting of an unexplained IUFD,
this test should be sent as soon as possible, since fetal
erythrocytes are rapidly removed from the maternal circulation. A
strongly positive KB test (for example, >30-mL) in the setting of
an unexplained IUFD may suggest that the likely cause of the demise
was feto-maternal hemorrhage. The KB test is positive in around 5-13%
of cases of unexplained IUFD (1,4).
Is there any utility in doing a fetal karyotype?
Because 5-10% of all stillborn infants will have chromosomal
abnormalities (5), a karyotype should be sent whenever fetal anatomic
malformations are noted. If the index of suspicion is high (for
example, if multiple structural anomalies were identified on
antepartum ultrasound), consideration should be given to performing
amniocentesis in the setting of IUFD to collect viable amniocytes for
analysis (6). Sampling of fetal tissues following delivery may have a
higher rate of failed karyotype analysis. If the fetus is noted to be
macerated, tissue from the umbilical cord or chorionic membranes
should be submitted for chromosomal analysis (1). Whether it is
necessary to check the karyotype of structurally normal fetuses,
however, is not clear.
What other test might be useful, and when should they be
performed?
Routine testing for the presence of congenital infections (such as
cytomegalovirus, herpes simplex virus, toxoplasmosis, and rubella)
either by culture or serologic testing are rarely useful (1,7).
Moreover, examination of the placenta will likely identify the vast
majority of infections (for example, microabscesses in the setting of
listeria or inclusion bodies in toxoplasmosis). If desired, serologic
testing should be performed as close to the event as possible in
order to better define the likely timing of the infection.
Other tests that are commonly sent include:
Table 1: Tests commonly sent to identify the cause of
IUFD
|
Test
|
Is test reliable in pregnancy?
|
|
Type and scre
|
Yes (screen all patients for isoimmunization)
|
|
VDRL or RPR
|
Yes (screen all patients for syphilis)
|
|
Serum glucose
|
No (screen for diabetes after puerperium)
|
|
Urine toxicology screen
|
Yes
|
|
Factor V Leiden deficiency
|
Yes (genetic test)
|
|
Prothrombin gene defect
|
Yes (genetic test)
|
|
MTHFR gene mutation
|
Yes (genetic test)
|
|
Hyperhomocysteinemia
|
Unknown (test for circulating levels)
|
|
Protein C deficiency
|
No (levels may increase in pregnancy)
|
|
Protein S deficiency
|
No (levels decrease in pregnancy)
|
|
Antithrombin III deficiency
|
No (levels may increase in pregnancy)
|
|
Lupus anticoagulant
|
Yes (ELISA test for circulating antibodies, but more
false-positive tests in pregnancy)
|
|
Anticardiolipin antibodies
|
Yes (ELISA test, but more false-positive tests in
pregnancy)
|
|
Antinuclear antibodies
|
Yes (ELISA test, but more false-positive tests in
pregnancy)
|
Reminder:
If you are a CME user and you logged in prior to reading this
question, don't forget to log out now!
References:
- Incerpi MH, Miller DA, Samadi R, Settlage RH, Goodwin TM.
Stillbirth evaluation: What tests are needed? Am J Obstet Gynecol
1998; 178:1121-5.
- Fretts RC, Boyd ME, Usher RH, Usher HA. The changing pattern
of fetal death, 1961-88. Obstet Gynecol 1992; 79:35-9.
- Pitkin RM. Fetal death: Diagnosis and management. Am J Obstet
Gynecol 1987; 157:583-9.
- Laube DW, Schauberger CW. Fetomaternal bleeding as a cause for
"unexplained" fetal death. Obstet Gynecol 1982; 60:649-51.
- Warburton D. Chromosomal causes of fetal death. Clin Obstet
Gynecol 1987; 30:268-77.
- American College of Obstetricians and Gynecologists. Genetic
evaluation of stillbirths and neonatal deaths. Committee Opinion
Number 257. Washington, DC: ACOG, May 2001.
- Benirschke K, Robb JA. Infectious causes of fetal death. Clin
Obstet Gynecol 1987; 30:284-94.
Site Editor:
Errol Norwitz, M.D., Ph.D.
Department of Obstetrics and Gynecology, Harvard Medical School
Founders
and Editors-in-Chief: Stephen B. Corn, M.D. and B. Scott Segal,
M.D.
Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School